We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,349 hedge funds and large institutions have $224B invested in Johnson & Johnson in 2017 Q1 according to their latest regulatory filings, with 112 funds opening new positions, 905 increasing their positions, 1,108 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 112 | Existing positions closed: 63

8% more capital invested

Capital invested by funds: $208B → $224B (+$16.6B)

5% more funds holding in top 10

Funds holding in top 10: 722759 (+37)

1% more funds holding

Funds holding: 2,3202,349 (+29)

0.15% more ownership

Funds ownership: 66.32%66.46% (+0.15%)

18% less repeat investments, than reductions

Existing positions increased: 905 | Existing positions reduced: 1,108

20% less call options, than puts

Call options by funds: $1.76B | Put options by funds: $2.2B

Holders
2,349
Holders Change
+29
Holders Change %
+1.25%
% of All Funds
58.48%
Holding in Top 10
759
Holding in Top 10 Change
+37
Holding in Top 10 Change %
+5.12%
% of All Funds
18.89%
New
112
Increased
905
Reduced
1,108
Closed
63
Calls
$1.76B
Puts
$2.2B
Net Calls
-$444M
Net Calls Change
+$360M
Name Holding Trade Value Shares
Change
Change in
Stake
FFA
401
First Foundation Advisors
California
$31.8M +$1.27M +10,645 +4%
V
402
Veritable
Delaware
$31.7M -$388K -3,251 -1%
WIC
403
Willis Investment Counsel
Georgia
$31.6M +$319K +2,670 +1%
MME
404
Meag Munich Ergo
Germany
$31.4M -$6.86M -57,440 -19%
JG
405
Jefferies Group
New York
$31.3M +$20.4M +170,608 +211%
SWITC
406
Stewart West Indies Trading Company
Colorado
$31.1M
MSE
407
MUFG Securities EMEA
United Kingdom
$31.1M +$29.9M +250,000 New
NIM
408
Northeast Investment Management
Massachusetts
$31.1M -$329K -2,756 -1%
OC
409
Oppenheimer & Co
New York
$30.9M -$3.31M -27,691 -10%
GCC
410
Guardian Capital (Canada)
Ontario, Canada
$30.6M -$544K -4,551 -2%
CTI
411
Community Trust & Investment
Kentucky
$30.4M +$439K +3,676 +2%
SIM
412
Sentry Investment Management
Wisconsin
$30.3M -$826K -6,918 -3%
TCM
413
Twin Capital Management
Pennsylvania
$30.1M -$554K -4,640 -2%
BFM
414
Boston Financial Management
Massachusetts
$30.1M +$503K +4,210 +2%
Baillie Gifford & Co
415
Baillie Gifford & Co
United Kingdom
$30M +$517K +4,328 +2%
HIC
416
Harvey Investment Company
Kentucky
$29.9M -$565K -4,732 -2%
ACM
417
Atlanta Capital Management
Georgia
$29.7M +$28.5M +238,740 New
SPC
418
Stewart & Patten Company
California
$29.5M +$158K +1,320 +0.6%
Daiwa Securities Group
419
Daiwa Securities Group
Japan
$29.4M -$4.13M -34,582 -13%
GJIC
420
Gamble Jones Investment Counsel
California
$29.2M -$852K -7,132 -3%
VNIM
421
Vaughan Nelson Investment Management
Texas
$29.1M -$5.61M -46,975 -17%
CC
422
Cannell & Co
New York
$28.8M -$1.64M -13,690 -6%
AIM
423
Avity Investment Management
Connecticut
$28.7M -$128K -1,068 -0.5%
RCM
424
RNC Capital Management
California
$28.7M +$1.46M +12,186 +6%
TGCM
425
Tukman Grossman Capital Management
California
$28.6M -$40.7M -340,392 -60%

JNJ Hedge Fund Activity: Q1 2017 in Review

2,349 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q1 2017, worth a combined $224B — up 8% from $208B a quarter earlier.

Buyers outnumbered sellers: 112 funds opened new JNJ positions and 63 closed out — a net gain of 49 holders — while 905 added to existing stakes and 1,108 trimmed.

The largest buyer was BlackRock, adding an estimated $19.5B. The largest seller was Fidelity Investments, cutting an estimated $850M.

  • 2,349 institutional investors held Johnson & Johnson (JNJ) as of Q1 2017, up from 2,320 in Q4 2016.
  • Funds reported $224B of Johnson & Johnson stock for Q1 2017, up 8% quarter-over-quarter.
  • 112 funds opened new Johnson & Johnson positions in Q1 2017 and 63 closed out, a net change of +49 holders.
  • The largest Johnson & Johnson buyer in Q1 2017 was BlackRock, an estimated $19.5B added.
  • The largest Johnson & Johnson seller in Q1 2017 was Fidelity Investments, an estimated $850M sold.

Based on aggregated 13F filings for Q1 2017.